Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |